Updates
** Shares of medical device maker Abbott ABT.N rise 5.4% to $133.05
** ABT is the top performer on the S&P 500 .SPX index on Wednesday
** Stock has its best day since April 2023, if gains hold
** ABT, in a conference call, says it doesn't expect any tariff impact in Q2
** Impact of tariffs is projected to be a few hundred million dollars in 2025 - company
** ABT reaffirms its annual profit per share forecast of between $5.05 and $5.25, but beats Q1 earnings estimate
** Company says two new manufacturing and R&D investments in Illinois and Texas, totaling $500 million, are projected to go live by the end of 2025
** Up to last close, stock up 11.6% YTD
(Reporting by Sriparna Roy and Puyaan Singh in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。